Loss-to-follow-up on multidrug resistant tuberculosis treatment in Gujarat, India: The when and who of it

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Shringarpure, Kalpita S ^a   Isaakidis, Petros ^b   Sagili, Karuna D ^c   Baxi, R K ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c Union   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMBULATORY CARE; ARTICLE; BACTERIUM CULTURE; COHORT ANALYSIS; DIRECTLY OBSERVED THERAPY; DRUG TREATMENT FAILURE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; FOLLOW UP; HUMAN; INDIA; LOSS TO FOLLOW UP; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; PATIENT DROPOUTS; RETROSPECTIVE STUDY; EPIDEMIOLOGY; MIDDLE AGED; RISK FACTOR; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

TUBERCULOSTATIC AGENT;

ADULT; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; INDIA; LOST TO FOLLOW-UP; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84940702509     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132543     Document Type: Article

References (21)

1. Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis. Elsevier Ltd; 2009; 9: 153-61. doi: 10.1016/S1473-3099(09)70041-6
2. Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One. 2009; 4: e6914. doi: 10.1371/journal.pone.0006914 PMID: 19742330
3. World Health Organization. Global Tuberculosis Report [Internet]. Zhurnal Eksperimental'noi i Teoreticheskoi Fiziki. 2013. Available: http://scholar.google.com/scholar?hl = en&btnG=Search&q = intitle:No+Title#0
4. Government of India. TB INDIA 2014 Revised National TB Control Programme Annual Status Report 2014.
5. State Health Society (RNTCP Sub Committee) CoH; Medical Services and Medical Education (HS). Gandhinagar. Annual status report 2013.
6. Omwega W TB in the shoes of TB defaulters [Internet]. Available: Available from: http://www.docstoc.com/docs/150002887/TB-in-the-shoes-of-tb-defaulters-arkangeloorg
7. Holtz T, Lancaster J. Risk factors associated with default from multidrug-resistant tuberculosis treatment, South Africa, 1999-2001. Int J Tuberc Lung Dis2006; 10: 649-655. Available: http://www.ingentaconnect.com/content/iuatld/ijtld/2006/00000010/00000006/art00010 PMID: 16776452
8. Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, et al. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis. 2002; 6: 780-8. Available: http://www.ncbi.nlm.nih.gov/pubmed/12234133 PMID: 12234133
9. Hasker E, Khodjikhanov M, Usarova S, Asamidinov U, Yuldashova U, van der Werf MJ, et al. Default from tuberculosis treatment in Tashkent, Uzbekistan; who are these defaulters and why do they default? BMC Infect Dis. 2008; 8: 97. doi: 10.1186/1471-2334-8-97 PMID: 18647400
10. Sanchez-Padilla E, Marquer C, Kalon S, Qayyum S, Hayrapetyan A, Varaine F, et al. Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia : A quantitative and qualitative study. 2014; 18: 160-167.
11. Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India. Revised National Tuberculosis Control Programme May 2012.www.tbcindia.nic.in
12. Cavanaugh JS, Kazennyy BY, Nguyen ML, Kiryanova E V, Vitek E, Khorosheva TM, et al. Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002-2005. Int J Tuberc Lung Dis. 2012; 16: 1069-74. doi: 10.5588/ijtld.11.0696 PMID: 22691694
13. Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, et al. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: An individual patient data meta-analysis of 9,153 patients. PLoS Med. 2012; 9: e1001300. doi: 10.1371/journal.pmed.1001300 PMID: 22952439
14. Chiang C-Y, Enarson D a, Yu M-C, Bai K-J, Huang R-M, Hsu C-J, et al. Outcome of pulmonary multidrug-resistant tuberculosis: A 6-yr follow-up study. Eur Respir J. 2006; 28: 980-5. doi: 10.1183/09031936.06.00125705 PMID: 16837502
15. Jeon DS, Shin DO, Park SK, Seo JE, Seo HS, Cho YS, et al. Treatment outcome and mortality among patients with multidrug-resistant tuberculosis in tuberculosis hospitals of the public sector. J Korean Med Sci. 2011; 26: 33-41. doi: 10.3346/jkms.2011.26.1.33 PMID: 21218027
16. Datta BS, Hassan G, Kadri SM, Qureshi W, Kamili A, Singh H, et al. Multidrug-Resistant and extensively drug resistant tuberculosis in Kashmir, India. 2008; 15-19.
17. Singla R, Sarin R, Khalid UK, Mathuria K, Singla N, Jaiswal a, et al. Seven-year DOTS-Plus pilot experience in India: results, constraints and issues. Int J Tuberc Lung Dis. 2009; 13: 976-81. Available: http://www.ncbi.nlm.nih.gov/pubmed/19723377 PMID: 19723377
18. Isaakidis P, Paryani R, Khan S, Mansoor H, Manglani M, Valiyakath A, et al. Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India. PLoS One. 2013; 8: e68869. doi: 10.1371/journal.pone.0068869 PMID: 23894358
19. Chiang, Centis R, Migliori GB. Invited Review Series: Drug-Resistant tuberculosis: Past, present, future. Respirology. 2010; 15: 413-432. doi: 10.1111/j.1440-1843.2010.01738.x PMID: 20337989
20. Isaakidis P, Rangan S, Pradhan A, Ladomirska J, Reid T, Kielmann K. "I cry every day": experiences of patients co-infected with HIV and multidrug-resistant tuberculosis. Trop Med Int Health. 2013; 18: 1128-33. doi: 10.1111/tmi.12146 PMID: 23837468
21. Sahu GB, Mahamallik M. Identification of the poor: Errors of exclusion and Inclusion. Economicand Political Weekly 2011; XLVI (9). http://www.epw.in/authors/motilal-mahamallik